<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04389541</url>
  </required_header>
  <id_info>
    <org_study_id>IOM-050408</org_study_id>
    <nct_id>NCT04389541</nct_id>
  </id_info>
  <brief_title>Clinical Research Platform on Decision Making and Clinical Impact of Biomarker-Driven Precision Oncology</brief_title>
  <acronym>INFINITY</acronym>
  <official_title>Clinical Research Platform on Decision Making and Clinical Impact of Biomarker-Driven Precision Oncology</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>iOMEDICO AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Bristol-Myers Squibb</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Roche Pharma AG</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>iOMEDICO AG</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The retrospective cohort study INFINITY will be an instrument to analyze the current practice&#xD;
      of precision oncology in the real-world setting. It will provide insight into real-world&#xD;
      biomarker-directed treatment of cancer patients not eligible for standard therapies. The&#xD;
      study will retrospectively collect medical records' data of patients who received a targeted&#xD;
      treatment based on a potentially actionable alteration or biomarker identified by molecular&#xD;
      diagnostics. Data of deceased patients will be included. The study will analyze how molecular&#xD;
      test results guided clinical decision making. The compiled treatment and outcome data will be&#xD;
      a valuable resource to analyze the use and effectiveness of targeted therapy approaches in&#xD;
      biomarker-defined and entity-defined subpopulations of cancer patients. These signals might&#xD;
      generate new insights and foster progress of targeted cancer treatment. The associated&#xD;
      biomarker profiling module aims to set up a decentral biobank for future research on&#xD;
      molecular alterations or central re-testing.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 17, 2020</start_date>
  <completion_date type="Anticipated">June 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2023</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>Overall response rate</measure>
    <time_frame>Maximum 5 years</time_frame>
    <description>Proportion of patients with CR or PR as best response</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient and Disease Characteristics</measure>
    <time_frame>maximum 5 years</time_frame>
    <description>Describe demographics, comorbidities and tumor type of patients not eligible for standard therapies.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Details on molecular diagnostics</measure>
    <time_frame>Maximum 5 years</time_frame>
    <description>Frequency of type of molecular diagnostic testing performed, of single gene/protein tests, multigene panels or NGS in molecular diagnostics, of type (by panel size) of NGS library sequenced, of proteins and genes tested, of altered proteins and genes, if tested, of treatment recommendations given in molecular diagnostic reports, of implemented treatment recommendations given in molecular diagnostic reports, of the use of a molecular tumor board (MTB), of implementation of the treatment recommendation given by MTB and duration from molecular testing result to start of non-standard targeted treatment</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical decision making</measure>
    <time_frame>Maximum 5 years (once per targeted therapy)</time_frame>
    <description>Frequency of answers rated with a Likert scale on patient's non-suitability for standard therapy options / choice of performed molecular diagnostics / choice of selected molecular target and targeted non-standard therapy / reasons for the selection of targeted non-standard therapy / primary goal of the non-standard targeted therapy / expected advantages of the non-standard targeted therapy and frequency of ESMO Scale of Clinical Actionability for molecular Targets (ESCAT) evidence levels</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of selected treatment approach assessed via project specific survey</measure>
    <time_frame>Maximum 5 years (once per completed targeted therapy)</time_frame>
    <description>Frequency of pre-defined answers on therapy duration, effectiveness and overall benefit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Best overall response</measure>
    <time_frame>Maximum 5 years</time_frame>
    <description>Proportion of patients with complete response (CR), partial response (PR), stable disease (SD) or progressive disease (PD)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Disease Control Rate</measure>
    <time_frame>Maximum 5 years</time_frame>
    <description>Proportion of patients with CR, PR or SD as best response</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Response</measure>
    <time_frame>Maximum 5 years</time_frame>
    <description>Time from start of treatment to the first objective tumor response (e.g., tumor shrinkage of ≥30%) observed for patients who achieved a CR or PR</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of Response</measure>
    <time_frame>Maximum 5 years</time_frame>
    <description>Time from documentation of tumor response to disease progression or death from any cause</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to treatment failure</measure>
    <time_frame>Maximum 5 years</time_frame>
    <description>Time from start of therapy to discontinuation of treatment for any reason, including progression, toxicity, and death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Progression-free survival</measure>
    <time_frame>Maximum 5 years</time_frame>
    <description>Time from start of treatment until disease progression or death</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PFS ratio</measure>
    <time_frame>Maximum 5 years</time_frame>
    <description>PFS ratio of targeted non-standard therapy and preceding treatment line</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall Survival</measure>
    <time_frame>Maximum 5 years</time_frame>
    <description>Time from start of treatment until death of any cause</description>
  </secondary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Advanced Solid Tumors or Hematologic Malignancies</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Tissue samples&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients with advanced solid tumors or hematologic malignancies not eligible for&#xD;
        standard therapies who received a targeted therapy based on an actionable alteration or&#xD;
        biomarker identified by molecular diagnostics&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Advanced solid tumors (i.e. locally advanced, inoperable and/or metastatic) or&#xD;
             hematologic malignancies not eligible for standard therapy options (i.e. without&#xD;
             further treatment options with drugs approved for the specific indication based on the&#xD;
             judgement of the treating physician)&#xD;
&#xD;
          -  Started or completed at the documenting study site a non-standard targeted therapy&#xD;
             based on an actionable alteration or biomarker identified by molecular diagnostics&#xD;
&#xD;
          -  Results on molecular diagnostics (e.g. tumor genomic or protein expression test) must&#xD;
             be available; based on these results the therapy decision was taken&#xD;
&#xD;
          -  Targeted therapy (given as monotherapy or as part of a therapy regimen) must be&#xD;
             non-standard at time point of patient registration in the eCRF&#xD;
&#xD;
          -  Age ≥ 18 years&#xD;
&#xD;
          -  Signed and dated informed consent form (only if patient is alive at time of data entry&#xD;
             into the project; not applicable for inclusion of deceased patients' data)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Non-standard targeted therapy was given within a clinical trial&#xD;
&#xD;
          -  The targeted therapy was given in a line of treatment for which it is non-standard&#xD;
             (e.g. treatment in first line instead of second line where it is approved); the&#xD;
             targeted therapy is however in principle approved for the given entity&#xD;
&#xD;
          -  The targeted therapy was non-standard because a certain prior treatment has not been&#xD;
             applied (e.g. targeted therapy is only approved after platin-based treatment but has&#xD;
             been given without prior platin-based treatment); the targeted therapy is however in&#xD;
             principle approved for the given entity&#xD;
&#xD;
          -  The targeted therapy was non-standard because a different or no chemotherapy back-bone&#xD;
             has been applied (e.g. targeted therapy is approved in combination with cisplatin but&#xD;
             has been given with oxaliplatin or without chemotherapy backbone); the targeted&#xD;
             therapy is however in principle approved for the given entity&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Norbert Marschner, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Outpatient center for hematology and oncology, Freiburg, Germany</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sina Grebhardt, PhD</last_name>
    <phone>+49 761 15242</phone>
    <phone_ext>0</phone_ext>
    <email>sina.grebhardt@iomedico.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>MVZ am Klinikum Aschaffenburg GmbH</name>
      <address>
        <city>Aschaffenburg</city>
        <zip>63739</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manfred Welslau, Dr.med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>MVZ am Klinikum Aschaffenburg</name>
      <address>
        <city>Aschaffenburg</city>
        <zip>63739</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manfred Welslau, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Studienzentrum Aschaffenburg</name>
      <address>
        <city>Aschaffenburg</city>
        <zip>63739</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silke Schirrmacher-Memmel, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Onkologische Schwerpunktpraxis</name>
      <address>
        <city>Augsburg</city>
        <zip>86152</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Margarete Plath, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hämatologisch-Onkologische Schwerpunktpraxis Bad Liebenwerda</name>
      <address>
        <city>Bad Liebenwerda</city>
        <zip>04924</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephan Kreher, PD Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sozialstiftung Bamberg Medizinisches Versorgungszentrum am Bruderwald gemeinnützige GmbH</name>
      <address>
        <city>Bamberg</city>
        <zip>96049</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christof Schweizer, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Onkologische Schwerpunktpraxis Bamberg</name>
      <address>
        <city>Bamberg</city>
        <zip>96052</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefan Fries, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Onkologisches Versorgungszentrum Friedrichshain</name>
      <address>
        <city>Berlin</city>
        <zip>10407</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Herbert Lebahn, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Onkologische Schwerpunktpraxis Kurfürstendamm</name>
      <address>
        <city>Berlin</city>
        <zip>10707</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ingo Tamm, PD. Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gemeinschaftspraxis für Onkologie und Hämatologie</name>
      <address>
        <city>Berlin</city>
        <zip>12627</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marcus Schweigert, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Evangelisches Waldkrankenhaus,Spandau,Innere Medizin I</name>
      <address>
        <city>Berlin</city>
        <zip>13589</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silke Polata, Dr.med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>MVZ Onkologischer Schwerpunkt am Oskar-Helene-Heim</name>
      <address>
        <city>Berlin</city>
        <zip>14195</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Markus Schuler, PD Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Onkologisch-Hämatologische Schwerpunktpraxis</name>
      <address>
        <city>Bremen</city>
        <zip>28209</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ralf Meyer, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Coburg Hämatologie, Onkologie</name>
      <address>
        <city>Coburg</city>
        <zip>96450</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christof Lamberti, PD Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Schwerpunktpraxis für Hämatologie und internistische Onkologie Coburg</name>
      <address>
        <city>Coburg</city>
        <zip>96450</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Zöller, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Onkologisches Zentrum Deggendorf</name>
      <address>
        <city>Deggendorf</city>
        <zip>94469</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicolas Graf, PD Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>BAG / Onkologische Gemeinschaftspraxis</name>
      <address>
        <city>Dresden</city>
        <zip>01307</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Illmer, PD Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Onkologische Gemeinschaftspraxis</name>
      <address>
        <city>Dresden</city>
        <zip>01307</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Johannes Mohm, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>MVZ Onkologie und Hämatologie am Sana Krankenhaus Gerresheim</name>
      <address>
        <city>Düsseldorf</city>
        <zip>40625</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Markus Dommach, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Praxis und Tagesklinik für gynäkologische Onkologie</name>
      <address>
        <city>Ebersberg</city>
        <zip>85560</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Isolde Gröll, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Essen Innere Klinik Tumorforschung</name>
      <address>
        <city>Essen</city>
        <zip>45147</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Schuler, PD Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Studienbüro CHOP GmbH</name>
      <address>
        <city>Frankfurt a.M.</city>
        <zip>60389</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hans Tesch, Prof. Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Agaplesion Markus Krankenhaus</name>
      <address>
        <city>Frankfurt a.M.</city>
        <zip>60431</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silvan Becker, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Praxis für interdisziplinäre Onkologie &amp; Hämatologie</name>
      <address>
        <city>Freiburg</city>
        <zip>79110</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nobert Marschner, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Praxis für interdisziplinäre Onkologie &amp; Hämatologie</name>
      <address>
        <city>Freiburg</city>
        <zip>79110</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthias Zaiss, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>MVZ II der Niels Stensen Kliniken Onkologie u. Hämatologie</name>
      <address>
        <city>Georgsmarienhütte</city>
        <zip>49124</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kerstin Lüdtke-Heckenkamp, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gemeinschaftspraxis Dres. Schmitt und Eulenbruch</name>
      <address>
        <city>Gerlingen</city>
        <zip>70839</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hans-Roland Schmitt, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Überörtliche Berufsausübungsgemeinschaft, MVZ Onkologische Kooperation Harz</name>
      <address>
        <city>Goslar</city>
        <zip>38642</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mark-Oliver Zahn, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>OSP Göttingen Dres. Meyer / Ammon / Metz</name>
      <address>
        <city>Göttingen</city>
        <zip>37073</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Metz, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gemeinschaftspraxis für Innere Medizin, Hämatologie, Onkologie, Gastroenterologie</name>
      <address>
        <city>Halle (Saale)</city>
        <zip>06110</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefanie Frank-Gleich, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hämatologisch-Onkologische Praxis Eppendorf (HOPE)</name>
      <address>
        <city>Hamburg</city>
        <zip>20249</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eray Gökkurt, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Studiengesellschaft Hämato-Onkologie Hamburg Prof. Laack &amp; Partner GbR</name>
      <address>
        <city>Hamburg</city>
        <zip>20251</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eckart Laack, Prof. Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hämatologisch-Onkologische Praxis Altona (HOPA)</name>
      <address>
        <city>Hamburg</city>
        <zip>22767</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gunter Schuch, PD Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Onkologische Schwerpunktpraxis</name>
      <address>
        <city>Hannover</city>
        <zip>30161</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eyck Von der Heyde, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>MediProjekt GbR</name>
      <address>
        <city>Hannover</city>
        <zip>30171</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Koenigsmann, Prof. Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gemeinschaftspraxis Dr. Haytham Kamal und Dr. David C. Dorn</name>
      <address>
        <city>Hannover</city>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Haytham Kamal, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Onkologische Schwerpunktpraxis</name>
      <address>
        <city>Heidelberg</city>
        <zip>69115</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefan Fuxius, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>SLK Kliniken Heilbronn Klinik für Innere Medizin III</name>
      <address>
        <city>Heilbronn</city>
        <zip>74078</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Uwe Martens, Prof. Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cancer Center Zweiseenland GbR</name>
      <address>
        <city>Herrsching</city>
        <zip>82211</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Max Hubmann, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Onkologische Schwerpunktpraxis im Medicinum</name>
      <address>
        <city>Hildesheim</city>
        <zip>31135</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Werner Freier, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Onkologische Schwerpunktpraxis Dres. Hansen &amp; Reeb</name>
      <address>
        <city>Kaiserslautern</city>
        <zip>67655</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard Hansen, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Kassel, Klinik für Onkologie und Hämatologie</name>
      <address>
        <city>Kassel</city>
        <zip>34125</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Wolf, Prof. Dr.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>MVZ Hämatologie und Onkologie Dr. Michael Neise &amp; Dr. André Lollert</name>
      <address>
        <city>Krefeld</city>
        <zip>47805</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Neise, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>PIOH - Praxis Internistische Onkologie und Hämatologie</name>
      <address>
        <city>Köln</city>
        <zip>50674</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marcel Reiser, PD Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gemeinschaftspraxis für Hämatologie und Onkologie, München MVZ GmbH</name>
      <address>
        <city>Köln</city>
        <zip>51103</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Achim Rothe, PD. Dr.med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Internisten am Markt</name>
      <address>
        <city>Köthen</city>
        <zip>06366</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Schwerdtfeger, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>ÜBAG - MVZ Dr. Vehling-Kaiser GmbH</name>
      <address>
        <city>Landshut</city>
        <zip>84036</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mike Haberkorn, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gemeinschaftspraxis für Hämatologie und Onkologie GbR</name>
      <address>
        <city>Lebach</city>
        <zip>66822</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefan Bauer, PD Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Onkologie UnterEms Leer-Emden-Papenburg</name>
      <address>
        <city>Leer</city>
        <zip>26789</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lothar Müller, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>MVZ Mitte am Johannisplatz</name>
      <address>
        <city>Leipzig</city>
        <zip>04103</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Albrecht Kretzschmar, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Mannheimer Onkologie Praxis</name>
      <address>
        <city>Mannheim</city>
        <zip>68161</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manfred Hensel, Prof. Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gemeinschaftspraxis für Hämatologie &amp; Onkologie</name>
      <address>
        <city>Moers</city>
        <zip>47441</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jörg Wiegend, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Brustzentrum Niederrhein im evangelischen Krankenhaus Bethesda</name>
      <address>
        <city>Mönchengladbach</city>
        <zip>41061</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Oleg Gluz, PD Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Praxis für Hämatologie, Onkologie &amp; Palliativmedizin</name>
      <address>
        <city>Mönchengladbach</city>
        <zip>41066</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ludger Sellmann, PD Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>MVZ Onkologie GmbH am Elisabeth-Krankenhaus Rheydt</name>
      <address>
        <city>Mönchengladbach</city>
        <zip>41239</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marcel Stephany, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gemeinschaftspraxis für Hämatologie internistische Onkologie</name>
      <address>
        <city>Mülheim an der Ruhr</city>
        <zip>45468</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan Schröder, PD Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medizinisches Zentrum für Hämatologie und Onkologie</name>
      <address>
        <city>München</city>
        <zip>80639</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christoph Salat, Prof. Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hämatologisch-onkologische Gemeinschaftspraxis</name>
      <address>
        <city>Münster</city>
        <zip>48149</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rüdiger Liersch, PD Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Friedrich-Ebert-Krankenhaus</name>
      <address>
        <city>Neumünster</city>
        <zip>24534</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Siegfried Haas, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>TZN - Tumorzentrum Niederrhein GmbH</name>
      <address>
        <city>Neuss</city>
        <zip>41462</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christoph Losem, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>MVZ Onko Medical GmbH Neustadt Innere, Med./Hämatologie-Onkologie</name>
      <address>
        <city>Neustadt Am Rübenberge</city>
        <zip>31535</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Barbara Tschechne, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Onkologie Offenburg Ambulantes Therapiezentrum für Hämatologie und Onkologie</name>
      <address>
        <city>Offenburg</city>
        <zip>77654</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Henning Pelz, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pius-Hospital Oldenburg Hämatologie, Onkologie</name>
      <address>
        <city>Oldenburg</city>
        <zip>26121</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frank Griesinger, Prof. Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Onkologische Praxis Passau</name>
      <address>
        <city>Passau</city>
        <zip>94036</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Reiner Sandnder, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Zentrum für Hämatologie und Onkologie MVZ GmbH</name>
      <address>
        <city>Porta Westfalica</city>
        <zip>32457</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Enno Moorahrend, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>MVZ für Blut- und Krebserkrankungen</name>
      <address>
        <city>Potsdam</city>
        <zip>14467</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Annette Sauer, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dr. Arnd Nusch</name>
      <address>
        <city>Ratingen</city>
        <zip>40883</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arnd Nusch, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Studienzentrum Onkologie Ravensburg</name>
      <address>
        <city>Ravensburg</city>
        <zip>88212</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Decker, Prof. Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Praxis und Tagesklinik für Onkologie und Hämatologie</name>
      <address>
        <city>Recklinghausen</city>
        <zip>45659</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Till-Oliver Emde</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Schwerpunktpraxis und Tagesklinik für Hämatologie und Onkologie</name>
      <address>
        <city>Regensburg</city>
        <zip>93053</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexander Kröber, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Praxis und Tagesklinik für Onkologie und Hämatologie</name>
      <address>
        <city>Remscheid</city>
        <zip>42853</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthias Klee, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Onkologische Praxis Remscheid</name>
      <address>
        <city>Remscheid</city>
        <zip>42859</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jörn Kohnke, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Schwerpunktpraxis im Ärztehaus Rheinbach</name>
      <address>
        <city>Rheinbach</city>
        <zip>53359</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Folke Lohse, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Praxis für Hämatologie und Internistische Onkologie</name>
      <address>
        <city>Rostock</city>
        <zip>18057</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Malte Leithäuser, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Südstadt Rostock Innere Medizin III</name>
      <address>
        <city>Rostock</city>
        <zip>18059</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Beate Krammer-Steiner, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>GPR Gesundheits- und Pflegezentrum Rüsselsheim</name>
      <address>
        <city>Rüsselsheim</city>
        <zip>65428</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dimitri Flieger, Prof. Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Zentrum Ambulante Onkologie</name>
      <address>
        <city>Schorndorf</city>
        <zip>73614</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dieter Bürkle, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Schwerpunktpraxis für Hämatologie und Internistische Onkologie, Gastroenterologie</name>
      <address>
        <city>Singen (Hohentwiel)</city>
        <zip>78224</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Fietz, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>MVZ Kloster Paradiese GbR</name>
      <address>
        <city>Soest</city>
        <zip>59494</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anke Wortmann, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hämatologie - Onkologie - Stolberg</name>
      <address>
        <city>Stolberg</city>
        <zip>52222</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthias Groschek</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kliniken Südostbayern - Klinikum Traunstein</name>
      <address>
        <city>Traunstein</city>
        <zip>83278</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Kubin, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Praxisnetzwerk Hämatologie / internistische Onkologie</name>
      <address>
        <city>Troisdorf</city>
        <zip>53840</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Helmut Forstbauer, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Onkologie Schwarzwald-Alb Dr. med. G. Köchling</name>
      <address>
        <city>Villingen-Schwenningen</city>
        <zip>78052</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Georg Köchling, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Praxen MVZ für Innere Medizin</name>
      <address>
        <city>Weinheim</city>
        <zip>69469</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dominik Bruckner, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gemeinschaftspraxis für Hämatologie und Onkologie</name>
      <address>
        <city>Westerstede</city>
        <zip>26655</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dietmar Reichert, Dr.med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Praxisgemeinschaft für Onkologie und Urologie</name>
      <address>
        <city>Wilhelmshaven</city>
        <zip>26389</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrea Distelrath, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Internistische Gemeinschaftspraxis,Hämatologie, Onkologie,Palliativmedizin</name>
      <address>
        <city>Worms</city>
        <zip>67547</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Birgit Reimann, Dr.med</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>MVZ West GmbH Würselen Hämatologie-Onkologie</name>
      <address>
        <city>Würselen</city>
        <zip>52146</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christoph Maintz, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hämatologisch-Onkologische, Schwerpunktpraxis Würzburg GbR,Dres. med. R. Schlag &amp; B. Schöttker</name>
      <address>
        <city>Würzburg</city>
        <zip>97080</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rudolf Schlag, Dr. med.</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Praxis und Tagesklinik für Hämatologie/Onkologie</name>
      <address>
        <city>Zittau</city>
        <zip>02763</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mathias Schulze, Dr. med.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>April 17, 2020</study_first_submitted>
  <study_first_submitted_qc>May 11, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 15, 2020</study_first_posted>
  <last_update_submitted>July 1, 2021</last_update_submitted>
  <last_update_submitted_qc>July 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hematologic Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

